IDEX Biometrics (IDEX.OL) Stock Analysis & AI Equity Report

Software - Application NOK Explore free reports

IDEX Biometrics (IDEX.OL) overview

IDEX Biometrics (IDEX.OL) stock analysis and AI equity research. For the latest completed financial year, 2024, IDEX Biometrics reported revenue of USD 0.8m and operating profit of USD -21.9m; the year-end share price was 6.79 NOK and market capitalisation was NOK 2,816m. IDEX Biometrics is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get IDEX Biometrics's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 4.7mFY 2024
Share price6.79 NOKFY 2024 year end
RevenueUSD 0.8mFY 2024
Operating profitUSD -21.9mFY 2024
Net earningsUSD -14.4mFY 2024
Market capitalisationNOK 2,816mFY 2024 year end

Figures updated on 2025-12-12. Data will be refreshed during report generation.

About IDEX Biometrics

IDEX Biometrics ASA develops and sells biometric authentication cards and related components for physical access, digital access, and payment use cases. Its products combine fingerprint sensors, secure elements, and software for card enrolment and management, and are sold to enterprises, public-sector customers, banks, issuers, and channel partners.

Generate the IDEX Biometrics report

IDEX Biometrics is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, typically within about 30 minutes

Sources & methodology

Financial figures are sourced from Valuatum's financial model for IDEX Biometrics and represent the latest completed financial year (2024). See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.